Top PDF Treatment of type 2 diabetes.
Treatment of type 2 diabetes.
... prevalence of type 2 diabetes and the risk of severe side-effects of oral antidiabetic agents are markedly increased with aging, special focus should be put on the specific group ...
13
Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus
... behalf of the REACH and REGAIN investigators a Institute of Clinical Trials and Methodology, University College London, London, UK; b Department of Endocrinology & Nutrition, Hospital de la Santa ...
14
DPP-4 inhibitors in the treatment of type 2 diabetes.
... administration of GLP-1 in cardiac insufficiency and myocardial infarction improves cardiac function by increasing left ventricular ejection fraction ...Administration of the DPP-4-resistant GLP-1 analog ...
27
Addition of incretin therapy to metformin in type 2 diabetes.
... the treatment of type 2 diabetes: a randomised, open-label, non-inferiority ...weeks of treatment. 69th Scientific Sessions of the American Diabetes ...
3
Pharmacokinetic evaluation of atorvastatin and sitagliptin in combination for the treatment of type 2 diabetes.
... use of FDC may offer the advantage of reducing the number of tablets to be taken and thereby increase patient's adherence to therapy ...[24,25]. Of note, atorvastatin was successfully combined ...
15
Targeting the AMPK pathway for the treatment of Type 2 diabetes.
... Benoît Viollet, Louise Lantier, Jocelyne Devin-Leclerc, Sophie Hébrard, Chloé Amouyal, et al... Tar- geting the AMPK pathway for the treatment of Type 2 diabetes...[r] ...
3
Canagliflozin: A Review in Type 2 Diabetes.
... oral treatment of type 2 diabetes ...independently of insulin, with the inhibition of SGLT2 reducing renal reabsorption of glucose and increasing excretion ...
20
Dulaglutide (LY-2189265) for the treatment of type 2 diabetes.
... cotransporter type 2 (SGLT2) inhibitors (gliflozins), [6] glucagon-like peptide-1 receptor agonists (GLP-1 RAs), [7] and ...selection of second-line agents and a similar approach may be used when ...
32
Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?
... abundance of co- morbidities, including type 2 diabetes ...modifications of the intestinal tract, is to date the most successful treatment for ...60% of patients even ...
48
Training-induced improvement in lipid oxidation in type 2 diabetes mellitus is related to alterations in muscle mitochondrial activity. Effect of endurance training in type 2 diabetes.
... including type 2 diabetes mellitus [12] and obesity, where training induced an increase in size and content of mitochondria [9] and enhanced mitochondrial fatty acid oxidation ...improvement ...
22
The endocannabinoid system: a promising target for the management of type 2 diabetes.
... hyperactivation of the EC tone in obesity. Since the early 1990s, a number of genetic polymorphisms in the genes and proteins of the EC system have been characterized ...role of genetic ...
49
An integrated approach for the identification of predictive markers of type 2 diabetes
... on 2 Jun 2020 HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or ...
2
Vitamin D and type 2 diabetes mellitus: Where do we stand?
... level of evidence from interventional studies is much more important than that of obser- vational or cross-sectional ...use of significant VTD supplementation to achieve potential benefits in T2DM, ...
8
Survival in people with type 2 diabetes as a function of HbA(1c).
... with type 2 ...results of earlier studies, an epidemiological study cannot show a causal relation, and such an observational database does not provide the detailed information that is available in a ...
4
Skin autofluorescence predicts cancer in subjects with type 2 diabetes
... measurement of AGE and it may be influenced by other fluorophores in the skin; neverthe- less, SAF does correlate with pentosidine, a common AGE, in skin ...with type 2 diabetes, and further ...
8
Preventing and treating kidney disease in patients with type 2 diabetes
... presence of microalbuminuria [ 9 ]. By analogy, the indication of ACE inhibi- tors in T2DM patients with albuminuria is now largely adopted, even in absence of hypertension but presence of ...
19
Skeletal muscle lipase content and activity in obesity and type 2 diabetes.
... ratio of DAGH to TAGH activity, suggesting incomplete TAG hydrolysis ...muscle of obese insulin- resistant men compared with the lean group, but rather a 30% ...development of skeletal muscle insulin ...
6
Hyperglycemia, type 2 diabetes, and depressive symptoms: the British Whitehall II study.
... (m 2 )], waist circumference (cm), systolic and diastolic blood pressure (mm Hg), HDL- and LDL-cholesterol (mmol/L), triglycerides (mmol/L), current smoking (yes/no), alcohol consumption (none, 1 to 3 units per ...
13
Rimonabant as an adjunct therapy in overweight/obese patients with type 2 diabetes.
... letter of the distinguished colleagues, Andre Scheen and Luc Van Gaal, and the opportunity to ...potential of rimonabant, the first representative of a new class of drugs, the CB1-receptor ...
1
Early life stress induces type 2 diabetes at adulthood in male mice
... induces type 2 diabetes at adulthood in male mice Hanna Ilchmann, Maiwenn Olier, Corinne Lencina, Sandrine Ellero-Simatos, Michèle Nankap, Ambre Riba, Caroline Sommer, Hervé Guillou, Laurence ...
2